Pfizer seeks full FDA approval of its Covid-19 vaccine
Full approval would allow the drugmaker — the first to seek full approval — to market the shot directly to consumers.
Full approval would allow the drugmaker — the first to seek full approval — to market the shot directly to consumers.
Full approval would allow the drugmaker — the first to seek full approval — to market the shot directly to consumers.
Full approval would allow the drugmaker — the first to seek full approval — to market the shot directly to consumers.